In this issue:
- Teplizumab in relatives at risk for type 1 diabetes
- Outcomes in offspring after use of metformin for gestational diabetes
- Bariatric surgery vs intensive medical therapy for diabetes
- Impact of CGM on glycaemic control in patients with type 2 diabetes treated with basal insulin
- Primary care-led weight management for remission of type 2 diabetes
- COVID-19 in people with diabetes
- SGLT-2 inhibitors and GLP-1 receptor agonists for type 2 diabetes
- Effects of lifestyle intervention vs metformin on diabetes development in at-risk patients
- Global trends in diabetes since 1980
- Advanced hybrid closed loop therapy in adults with type 1 diabetes
- Novel subgroups of adult-onset diabetes
- Time in range is a useful outcome measure for diabetes trials
- Impact of low-fat diets vs other diets on long-term weight change
Please login below to download this issue (PDF)